Related Experiment Video
Updated: Jun 5, 2026

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection
Published on: December 8, 2014
Systematic review: Clostridium difficile and inflammatory bowel disease.
J R Goodhand1, W Alazawi, D S Rampton
1Blizard Institute of Cell and Molecular Science, Queen Mary's University, London, UK.
Clostridium difficile infection (CDI) is increasingly recognized in inflammatory bowel disease (IBD) patients. However, evidence for rising incidence and worsening outcomes in IBD requires further investigation, necessitating urgent therapeutic trials.
Area of Science:
- Gastroenterology
- Infectious Diseases
- Microbiology
Background:
- Growing concern exists regarding the incidence and outcomes of Clostridium difficile infection (CDI) in patients with inflammatory bowel disease (IBD).
- A systematic literature review was conducted to assess CDI in IBD, focusing on incidence, risk factors, endoscopic findings, treatment, and outcomes.
Purpose of the Study:
- To systematically review the existing literature on Clostridium difficile and inflammatory bowel disease.
Main Methods:
- Searched PubMed for original, cross-sectional, cohort, and case-controlled studies published up to September 2010.
- Included 42 studies out of 407 initial results, noting heterogeneity that prevented meta-analysis.
Main Results:
- CDI is more prevalent in active IBD, especially ulcerative colitis, compared to controls.
- Risk factors include immunosuppressants and antibiotics; however, the temporal trend of increasing CDI incidence in IBD is uncertain due to potential biases.
- Endoscopic findings like pseudomembranes are uncommon and unhelpful for CDI diagnosis in IBD patients.
- Outcomes for hospitalized IBD patients with CDI appear worse than for controls.
Conclusions:
- While CDI in IBD has gained attention, its increasing incidence and worsening outcomes remain unproven.
- There is a critical lack of controlled therapeutic trials for CDI in IBD patients, highlighting an urgent need for such research.
Related Concept Videos
Inflammatory Bowel Disease III: Crohn's Disease
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory Bowel Disease I: Introduction
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease II: Ulcerative Colitis
Inflammatory Bowel Disease IV: Clinical Manifestations
